key: cord-0835173-6cmubqig authors: Kumari, Sarita title: Gynaecologic cancer care during COVID‐19 pandemic in India: a social media survey date: 2020-09-17 journal: Cancer Rep (Hoboken) DOI: 10.1002/cnr2.1280 sha: f220f30bbf4fc83cb592974a4eb6b8d355a34b92 doc_id: 835173 cord_uid: 6cmubqig BACKGROUND: Health care services across the globe are undergoing a major transformation to combat the coronavirus disease 2019 (COVID‐19) pandemic. Regardless of the strength of health care infrastructure across different economies, all countries are diverting their resources toward care for COVID‐19 patients. AIM: The aim of this survey was to evaluate the pattern of care of gynaecologic cancers in a developing country during the COVID‐19 pandemic. METHODS: An anonymous survey consisting of 20 questions intended for the gynaecologic cancer care providers with emphasis on their current practice and approach to their patients was distributed online via social media from April 30 to May 31, 2020. Basic descriptive statistics were applied. RESULTS: Among a total of 61 respondents, 63.9% were gynaecologic oncologists, 18.0% were radiation oncologists and 18.0% were medical oncologists. Majority, that is, 95.1% health care professionals felt that COVID‐19 pandemic has had a significant change on their practice pattern and 56.2% practitioners had stopped registering new cases of cancer. In 75.4% centers surgery was being done for gynaecologic cancer cases and among them 60.8% were doing surgery only for cases requiring immediate intervention. Among the centers providing chemotherapy, 39.1% had switched to oral drugs. Among the centers providing radiation, 40.9% were providing radiation to cases based on their type and urgency and 9.0% had implemented hypofractionation. In early stage low risk cases, majority, that is, 34.0% centers were managing as before. In early stage high‐risk cases, 32.6% centers were managing as before. In advanced stage endometrial cancer cases, 28.8% had postponed any treatment and 28.8% administered chemotherapy. In early stage, epithelial ovarian cancer 65.9% centers were performing complete staging of the disease. In advanced stage epithelial ovarian cancer, 65.9% centers preferred biopsy followed by neoadjuvant chemotherapy and 11.3% centers performed primary debulking surgery. In cases of interval debulking surgery, 73.3% centers deferred surgery till all six cycles of chemotherapy was completed. In cases of recurrent ovarian cancer amenable for secondary debulking surgery, 38.6% preferred chemotherapy. In early stage cervical cancer, surgical treatment was provided in 46.5% centers. In locally advanced cervical cancer, chemoradiation was given in 65.9% centers. In cases of metastatic cervical cancer, 46.6% centers were performing palliative radiation. CONCLUSION: COVID‐19 has affected the treatment of gynecologic cancers patients and health care professionals are trying to mitigate the damage by incorporating new elements which are suited to the current scenario. cancer, chemoradiation was given in 65.9% centers. In cases of metastatic cervical cancer, 46.6% centers were performing palliative radiation. Conclusion: COVID-19 has affected the treatment of gynecologic cancers patients and health care professionals are trying to mitigate the damage by incorporating new elements which are suited to the current scenario. Patients with cancer are struggling to receive treatment. Even in patients having curable cancer and without any comorbidities, who will derive therapeutic benefit form timely care, treatment is being postponed considering the risk of contracting COVID-19 may outweigh the benefits of cancer treatment. Several medical societies have come up with guidelines for oncology care providers during pandemic. [3] [4] [5] However, resources addressing the quality of current practice remain scarce. Amidst all these dilemmas we thought of implementing a survey to see the pattern of cancer care among gynaecologic cancer cases in India. We constructed a survey consisting of 20 questions intended for the gynaecologic cancer care providers with emphasis on their current practice and approach to their patients. Freely available online survey tool (www.surveymonkey.com) was used to create the survey. The survey was structured to capture general anonymous data of respondents. It was up to the respondents to choose whether or not to answer any question in the survey, thus each question was not necessarily answered by all respondents. The percentages were counted from those who answered a certain question and not from the entire cohort (the denominator was the number of respondents to each single question). Moreover, some questions allowed multiple options to be selected. Questions were directed to the most common gynaecologic cancers, that is, carcinoma endometrium, carcinoma ovary and carcinoma cervix and the results are presented here. On April 30, after creating a social media link the survey was sent to gynaecologic oncologists, medical oncologists and radiation oncologists across all hospitals catering to cancer patients in different states through email, Twitter, Facebook and Whatsapp and the survey was closed on May 31, 2020. Data were analyzed using inbuilt software in the survey tool. Descriptive statistics in terms of frequency and percentage were used to analyze the results of this study. gave only therapeutic radiation and 1 (2.2%) center gave only palliative radiation. In cases of metastatic cervical cancer, 21 (46.6%) centers were performing palliative radiation, 13 (28.8%) only did symptom palliation, 7 (15.5%) postponed the treatment and 4 (8.8%) made no changes in the treatment protocol. Figure 4 depicts the above findings. The authors have stated explicitly that there are no conflicts of interest in connection with this article. Completion of survey was considered as written informed consent for participation. The data that support the findings of this study are available from the corresponding author upon reasonable request. ORCID Sarita Kumari https://orcid.org/0000-0003-4687-1058 Director-General's opening remarks at the media briefing on COVID-19 COVID-19 Patient Care Information Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan Minimally invasive surgery at the time of COVID-19: the OR staff needs protection Cancer patients affected by COVID-19: experience from Milan Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery Gynecologic oncology at the time of COVID-19 outbreak Management of patients with ovarian cancer in the COVID-19 era Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey How to cite this article: Kumari S. Gynaecologic cancer care during COVID-19 pandemic in India: a social media survey